Background The increasing number of patients with Ebstein anomaly (EA) surviving into
adulthood implies improvements in the treatments for the complex lesion. We revisited the …

Background Low birth prevalence and referral bias constitute significant obstacles to
elucidating the natural history of Ebstein anomaly (EA). Objectives An extensive 2-country …

OBJECTIVES Our goal was to evaluate the impact of the adult congenital heart disease
anatomical and physiological (ACHD AP) classification system on the surgical management …

Introduction: Ebstein's anomaly (EA) accounts for less than 1% of all congenital heart
disease (CHD) and outcome data in adults is scarce. In our adult CHD centre, we have …

Background: Ebstein's anomaly (EA) is a malformation of the tricuspid valve (TV) and
myopathy of the right ventricle (RV). Surgery is now the main treatment for the defect …

Background Forecasting the prognosis of a child when diagnosed with Ebstein's anomaly is
difficult. We, therefore, studied which factors at the time of diagnosis are associated with …

ObjectivesTo assess clinical presentation, treatment, and outcome of children with Ebstein's
anomaly. BackgroundData on long-term outcome of children with Ebstein's anomaly are …

Ebstein's anomaly (EA) is a rare but fascinating congenital heart disorder accounting for<
1% of all congenital heart defects. Since its description in 1866, dramatic advances in …

OBJECTIVE: The purpose of this study was to review the long-term outcome of patients with
Ebstein anomaly who underwent complete repair as neonates and young infants …

Aims Survival rates for unoperated patients with Ebstein's anomaly (EA) are unknown. We
estimated overall long-term mortality in operated and unoperated EA patients, compared …